ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Funds New Centers At Stanford, Baylor.

June 15, 2007

NY Attorney General Subpoenaes Amgen, J&J Over ESA Promotion.

May 25, 2007

IARC Finds Limited Evidence That Residential Magnetic Fields Raise Leukemia Risk.

June 29, 2001

High-Dose Chemo Doesn’t Improve Survival In Small Cell Lung Cancer

April 25, 2008

In Brief: Congressional Action Imminent On Cancer Ac Renewal, Hew Money Bills; Veto Threatened

September 8, 1978

Amgen’s Aranesp Sales Dropped By Half, Continue To Fall.

November 14, 2008